vs
Side-by-side financial comparison of Opus Genetics, Inc. (IRD) and Nano Labs Ltd (NA). Click either name above to swap in a different company.
Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.7M, roughly 1.4× Nano Labs Ltd).
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
Weebit Nano is a public semiconductor IP company founded in Israel in 2015 and headquartered in Hod HaSharon, Israel. The company develops Resistive Random-Access Memory technologies. Resistive Random-Access Memory is a specialized form of non-volatile memory (NVM) for the semiconductor industry. The company's products are targeted at a broad range of NVM markets where persistence, performance, and endurance are all required. ReRAM technology can be integrated in electronic devices like weara...
IRD vs NA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $2.7M |
| Net Profit | — | $20.3M |
| Gross Margin | — | — |
| Operating Margin | — | — |
| Net Margin | — | 754.5% |
| Revenue YoY | -10.2% | — |
| Net Profit YoY | 53.0% | — |
| EPS (diluted) | — | $1.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9M | $2.7M | ||
| Q3 25 | $3.1M | — | ||
| Q2 25 | $2.9M | $1.2M | ||
| Q1 25 | $4.4M | — | ||
| Q4 24 | $4.3M | — | ||
| Q3 24 | $3.9M | — | ||
| Q2 24 | $1.1M | $3.5M | ||
| Q1 24 | $1.7M | — |
| Q4 25 | — | $20.3M | ||
| Q3 25 | $-17.5M | — | ||
| Q2 25 | $-7.4M | $-985.5K | ||
| Q1 25 | $-8.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-7.5M | — | ||
| Q2 24 | $-7.8M | $-8.0M | ||
| Q1 24 | $-7.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | -269.9% | — | ||
| Q2 25 | -309.0% | -459.2% | ||
| Q1 25 | -227.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -207.1% | — | ||
| Q2 24 | -748.9% | -237.2% | ||
| Q1 24 | -450.5% | — |
| Q4 25 | — | 754.5% | ||
| Q3 25 | -566.9% | — | ||
| Q2 25 | -257.5% | -85.2% | ||
| Q1 25 | -187.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -194.6% | — | ||
| Q2 24 | -698.3% | -231.3% | ||
| Q1 24 | -415.3% | — |
| Q4 25 | — | $1.03 | ||
| Q3 25 | $-0.25 | — | ||
| Q2 25 | $-0.12 | $-0.06 | ||
| Q1 25 | $-0.24 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.29 | — | ||
| Q2 24 | $-0.30 | $-0.12 | ||
| Q1 24 | $-0.29 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $45.1M | $4.9M |
| Total DebtLower is stronger | — | $24.5M |
| Stockholders' EquityBook value | $15.3M | $106.5M |
| Total Assets | $50.2M | $159.3M |
| Debt / EquityLower = less leverage | — | 0.23× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.1M | $4.9M | ||
| Q3 25 | $30.8M | — | ||
| Q2 25 | $32.4M | $50.8M | ||
| Q1 25 | $41.8M | — | ||
| Q4 24 | $30.3M | — | ||
| Q3 24 | $36.6M | — | ||
| Q2 24 | $41.4M | $3.3M | ||
| Q1 24 | $47.2M | — |
| Q4 25 | — | $24.5M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $24.8M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $22.5M | ||
| Q1 24 | — | — |
| Q4 25 | $15.3M | $106.5M | ||
| Q3 25 | $6.0M | — | ||
| Q2 25 | $17.5M | $86.8M | ||
| Q1 25 | $5.1M | — | ||
| Q4 24 | $6.7M | — | ||
| Q3 24 | $34.3M | — | ||
| Q2 24 | $40.6M | $-5.1M | ||
| Q1 24 | $46.1M | — |
| Q4 25 | $50.2M | $159.3M | ||
| Q3 25 | $36.1M | — | ||
| Q2 25 | $38.7M | $206.4M | ||
| Q1 25 | $48.2M | — | ||
| Q4 24 | $36.9M | — | ||
| Q3 24 | $40.4M | — | ||
| Q2 24 | $44.8M | $51.2M | ||
| Q1 24 | $51.8M | — |
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-35.3M | $-8.3M |
| Free Cash FlowOCF − Capex | — | $-8.4M |
| FCF MarginFCF / Revenue | — | -312.3% |
| Capex IntensityCapex / Revenue | — | 2.9% |
| Cash ConversionOCF / Net Profit | — | -0.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-35.3M | $-8.3M | ||
| Q3 25 | $-6.2M | — | ||
| Q2 25 | $-10.3M | $-7.1M | ||
| Q1 25 | $-9.0M | — | ||
| Q4 24 | $-25.6M | — | ||
| Q3 24 | $-5.1M | — | ||
| Q2 24 | $-7.3M | $-10.8M | ||
| Q1 24 | $-5.7M | — |
| Q4 25 | — | $-8.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-7.2M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-15.4M | ||
| Q1 24 | — | — |
| Q4 25 | — | -312.3% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -620.3% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -443.4% | ||
| Q1 24 | — | — |
| Q4 25 | — | 2.9% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 7.2% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 133.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | -0.41× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
